Imaging Flow Cytometry With Spatial Coding for Parallel Biomarker Assays

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing detection methods for biological particles, such as flow cytometry and fluorescence microscopy, are limited in throughput and spatial resolution, unable to efficiently detect 10^2 to 10^5 different objects simultaneously, and spatially coded reagents smaller than 100 nm cannot be effectively resolved by imaging flow cytometry.

Innovation Solution

A method combining imaging flow cytometry with spatially coded reagents, using fluorescent microspheres of different colors and spatial positions to form coding sequences, enabling high-throughput parallel detection of biological particles, nucleic acids, proteins, and single cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional flow cytometry is used for high-throughput detection, then detection speed can reach 10^3 particles per second, but the number of parallel assays is limited to 50 different analytes due to spectral width constraints

Engineering Contradiction:
Improvedetection throughputVSAvoidnumber of parallel assays
Core Design Contradiction:
ProductivityVSAdaptability or versatility

Solution Approach 1:

The patent transitions from spectral coding (1D wavelength dimension) to spatial coding (2D position dimension) of fluorescent microspheres. By arranging microspheres with different fluorescence colors in specific spatial positions, the system achieves combinatorial coding capacity of 10^2 to 10^5 different analytes while maintaining high detection throughput, effectively resolving the contradiction between throughput and parallel assay capacity.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Adaptability or versatility

If spatially coded reagents with smaller size are used to increase coding capacity, then more analytes can be detected in parallel, but detection accuracy decreases when size is below 100 nm

Engineering Contradiction:
Improvecoding capacityVSAvoiddetection accuracy
Core Design Contradiction:
Adaptability or versatilityVSMeasurement precision

Solution Approach 1:

The patent optimizes the size parameter of fluorescent microspheres to be within 100-1000 nm, which is large enough to be effectively resolved by imaging flow cytometry (maintaining detection accuracy) while still enabling high coding capacity through spatial arrangement. This parameter optimization resolves the contradiction between coding capacity and detection accuracy.

Inventive Principle:
Principle #35Parameter changes

3Adaptability or versatility

If more fluorescent labels with different colors are used to increase parallel detection capacity, then more analytes can be detected, but spectral overlap increases making differentiation difficult

Engineering Contradiction:
Improveparallel detection capacityVSAvoidfluorescence differentiation accuracy
Core Design Contradiction:
Adaptability or versatilityVSMeasurement precision

Solution Approach 1:

The patent moves from relying solely on spectral differentiation (1D wavelength) to spatial-spectral combined coding (2D position + wavelength). By encoding information in both the spatial position and fluorescence color of microspheres, the system achieves high parallel detection capacity while maintaining accurate differentiation through the added spatial dimension, effectively resolving the spectral overlap problem.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Achieves high-throughput parallel detection of 10^2 to 10^5 biological particles per second, with improved accuracy and efficiency, suitable for liquid biopsy applications.

Implementation Method 1

selecting fluorescent labels having small fluorescence spectral overlap, labeling the surface of microspheres with the fluorescent labels

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentEP4667903A1High-throughput parallel testing method based on imaging flow cytometry and spatially coded reagent
Publication Date: 2025.12.24 FAIRY LIFE SCIENCES (WUHAN) CO LTD
  • EP4667903A1 patent drawingFigure 1
  • EP4667903A1 patent drawingFigure 2
  • EP4667903A1 patent drawingFigure 3

AI summary

A high-throughput parallel testing method based on imaging flow cytometry and spatially coded reagents combines the high-throughput characteristic of an imaging flow cytometer and the high coding capacity characteristic of spatially coded reagents, thereby achieving high-throughput parallel testing of nucleic acid sequencing, protein testing and single cell analysis, and being capable of being used for liquid biopsy or other biomedical use requirements for performing high-throughput synchronous testing on different biomarkers.